Telos Corporation
NASDAQ:TLSInformation Technology Services
-$0.01 today
- Market cap
- $544.88M
- Beta
- 0.97
- P/E (TTM)
- -12.4
- EPS (TTM)
- -$0.35
Volume 0.84M
Average 0.87M
TLS Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Telos CorporationNASDAQ: TLS
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin narrows to 36.4%
Gross margin was 36.4% in Q1 FY2026, down 3.0 pp from a year earlier. On a trailing-twelve-month basis it was 36.5%, down 0.6 pp year over year. Over 3 fiscal years it widened by 0.6 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 37.0%
- Year-over-year change
- +5.2pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 37.0% | +5.2pp |
| FY2024 | 2024-12-31 | 31.8% | -4.6pp |
| FY2023 | 2023-12-31 | 36.4% | -0.0pp |
| FY2022 | 2022-12-31 | 36.4% | +1.0pp |
| FY2021 | 2021-12-31 | 35.5% | — |
Gross Margin vs competitors
How TLS compares with its peers on the latest reported figures
- TLS's LTM Mar 2026 gross margin of 36.5% is the 6th highest of the 9 companies compared; the peer median is 38.1%.
- Its year-over-year change of -0.6 pp is the 4th highest of 9, against a peer median of -1.5 pp.
- Over three fiscal years its change of +0.6 pp compares with a peer median of -3.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 78.3% | +8.5 pp | +5.2 pp | |
| LTM Mar 2026 | 70.5% | -1.6 pp | +2.9 pp | |
| LTM Mar 2026 | 48.4% | -9.0 pp | -18.6 pp | |
| LTM Mar 2026 | 39.5% | +1.0 pp | -1.0 pp | |
| LTM Mar 2026 | 36.6% | -1.5 pp | -5.8 pp | |
| LTM Mar 2026 | 36.5% | -0.6 pp | +0.6 pp | |
| LTM Mar 2026 | 28.3% | -2.6 pp | +6.8 pp | |
| LTM Mar 2026 | 25.7% | -5.4 pp | -5.5 pp | |
| LTM Mar 2026 | 15.2% | +2.9 pp | -16.6 pp | |
NBPNovaBridge Biosciences | FY2025 | — | — | — |
| Peer median (excluding TLS) | 38.1% | -1.5 pp | -3.3 pp | |
Competitors are the stored peer set for TLS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 242.43M | 216.89M | 145.38M | 108.27M | 164.81M |
| Cost of Revenue | 156.4M | 137.84M | 92.44M | 73.84M | 103.79M |
| Gross Profit | 86.03M | 79.04M | 52.94M | 34.43M | 61.02M |
| Gross Margin | 35.5% | 36.4% | 36.4% | 31.8% | 37.0% |
| Research & Development | 19.1M | 16.92M | 12.25M | 8.44M | 7.06M |
| Selling, General & Admin | 108.4M | 115.98M | 81.01M | 75.49M | 78.93M |
| Operating Expenses | 127.49M | 132.89M | 93.26M | 90.3M | 85.53M |
| Depreciation & Amortization | 5.62M | 5.89M | 9.43M | 11.87M | 11.45M |
| EBITDA | (36.76M) | (46.61M) | (24.17M) | (39.98M) | (25.21M) |
| EBITDA Margin | -15.2% | -21.5% | -16.6% | -36.9% | -15.3% |
| Operating Income | (41.46M) | (53.85M) | (40.32M) | (55.87M) | (24.47M) |
| Operating Margin | -17.1% | -24.8% | -27.7% | -51.6% | -14.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 777K | 874K | 786K | 644K | 553K |
| Other Income / Expenses | (1.7M) | 476K | 5.93M | 3.38M | (12.74M) |
| Income Before Tax | (43.16M) | (53.37M) | (34.39M) | (52.49M) | (37.21M) |
| Pre-Tax Margin | -17.8% | -24.6% | -23.7% | -48.5% | -22.6% |
| Income Tax Expense | (28K) | 54K | 36K | 26K | (663K) |
| Net Income | (43.13M) | (53.43M) | (34.42M) | (52.52M) | (36.55M) |
| Net Margin | -17.8% | -24.6% | -23.7% | -48.5% | -22.2% |
| EPS (Basic) | (0.65) | (0.79) | (0.50) | (0.73) | (0.50) |
| EPS (Diluted) | (0.65) | (0.79) | (0.50) | (0.73) | (0.50) |
| Weighted Avg Shares | 66.37M | 67.56M | 69.26M | 71.85M | 72.88M |
| Weighted Avg Shares (Diluted) | 66.37M | 67.56M | 69.26M | 71.85M | 72.88M |
Telos Corporation
NASDAQ:TLS
Intrinsic Alpha fair value
Locked
Current Price
$7.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.